Zhitong Financial App News, Near Shore Protein (688137.SH) issued a notice on serious abnormal stock trading fluctuations and risk alerts, stating that the company's revenue from RNA vaccine drug-related products in 2025 accounted for 11.38% of total product revenue (see 2025 Annual Report for details), which is relatively low.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.